Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Newron Pharmaceuticals SpA    NWRN   IT0004147952

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Newron Pharmaceuticals SpA
Discovers and develops small molecule drugs

Newron Pharmaceuticals SpA engages in the research and development of drugs for the treatment of central nervous system disorders and pain.

It operates through a single business segment which is the Research and Development of Pharmaceutical drugs.

The company was founded by Luca Benatti, Ruggero Fariello, and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.
Sales per Businesses
20122013Delta
CHF (in Million)%CHF (in Million)%
Pharmaceuticals10.73100%3.95100% -171.43%
Surperformance© rating of Newron Pharmaceuticals SpA
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential - - -
Yield - - -
Consensus - - -
7 days EPS revision
4 months EPS revision
1 year EPS revision - - -
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Advertisement
Sector Pharmaceuticals - Diversified
Trading RatingInvestor Rating
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
Sector Pharmaceuticals - Diversified
Company contact information
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso, Milan 20091

Phone : +39.02.610.3461
Fax : +39.02.610.34654
Web : www.newron.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF